{
  "id": 1978310,
  "title": "Moderna, Merck Revive mRNA Hopes With Melanoma Success",
  "url": "https://urgent.news/2026/08/19/moderna-merck-revive-mrna-hopes-with-melanoma-success",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-19T16:51:50.000Z",
  "source": {
    "name": "Bloomberg",
    "slug": "bloomberg",
    "url": "https://www.bloomberg.com/news/videos/2026-08-19/moderna-merck-revive-mrna-hopes-with-melanoma-success"
  },
  "original_language": "en",
  "account": null,
  "summary": "A personalized vaccine developed by Moderna and Merck reduced the recurrence of melanoma in a large, late-stage trial, raising expectations for treating the deadliest form of skin cancer and showing the promise of the embattled mRNA technology. Madison Muller explains (Source: Bloomberg)",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Financial Post",
        "title": "Moderna and Merck shares surge after melanoma vaccine success",
        "url": "https://urgent.news/2026/08/19/moderna-and-merck-shares-surge-after-melanoma-vaccine-success",
        "published": "2026-08-19T16:29:20.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}